MetaCap

Astrotech (DE) (ASTC) vs Seer (SEER)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Astrotech (DE) (ASTC) has outperformed Seer (SEER) over the past year, gaining 28.2% versus a loss of 31.0%. Over five years, ASTC leads with a -85.6% price change compared with -94.1% for SEER. Seer is the larger company by market cap ($75.9 million vs $7.4 million), about 10.2 times the size.

Seer converts more of its revenue into profit, with a net margin of -444.0% versus -1580.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASTC+28.21%SEER-30.96%
+1812%+847%-119%
Nov 21, 20251 yearNov 20, 2026
ASTC-85.77%SEER-94.62%
+112%+4%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASTC versus SEER key metrics
MetricASTCSEER
Share price$3.50$1.36
Market cap$7.45M$75.91M
1-day change-0.85%-1.81%
YTD return+1.16%-25.68%
1-year return+28.21%-30.96%
5-year return-85.60%-94.05%
EPS (TTM)$-7.88$-1.14
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$913.00K$16.58M
Revenue growth (YoY)-8.70%+16.99%
Net income (latest FY)$-14.43M$-73.60M
Gross margin23.77%51.06%
Operating margin-1548.52%-470.45%
Net margin-1580.18%-443.96%
52-week high$68.85$2.38
52-week low$1.92$1.33
Distance from 52-week high-94.92%-42.74%
Analyst consensus—strong_buy
Avg. price target upside—+194.12%
Average volume30.46K216.28K
Shares outstanding2.13M55.81M
Employees—124
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Seer is about 10.2 times larger than Astrotech (DE) by market value ($75.91M vs $7.45M).
  • ASTC has outperformed SEER by 59.2 percentage points over the past year.
  • Seer is more profitable, keeping -444.0 cents of every revenue dollar as net income versus -1580.2 cents for Astrotech (DE).
  • Seer grew revenue faster in its latest fiscal year (+16.99% vs -8.70%).

About Astrotech (DE)

ASTC stock →

Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology.

Industrials · Biotechnology: Laboratory Analytical Instruments

About Seer

SEER stock →

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees

ASTC vs SEER FAQ

Which is bigger, Astrotech (DE) or Seer?

Seer (SEER) is larger, with a market capitalization of $75.91M compared with $7.45M for Astrotech (DE) (ASTC).

Which stock has performed better over the past year, ASTC or SEER?

ASTC returned +28.21% over the past 12 months, compared with -30.96% for SEER (price return, excluding dividends). Past performance does not predict future results.

Are Astrotech (DE) and Seer in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons